Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
50%(2 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_4
3
43%
Ph phase_3
1
14%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

withdrawn114%
active_not_recruiting114%
completed457%
recruiting114%

Recent Activity

2 active trials
Showing 5 of 7
completedphase_4

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

NCT05579249
active_not_recruiting

Anti-obesity Pharmacotherapy and Inflammation

NCT05756764
recruitingphase_4

Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

NCT06620562
completedphase_3

Individualized Obesity Pharmacotherapy

NCT03374956
withdrawnphase_4

Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery

NCT04399395
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05579249Phase 4

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Completed
NCT05756764

Anti-obesity Pharmacotherapy and Inflammation

Active Not Recruiting
NCT06620562Phase 4

Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

Recruiting
NCT03374956Phase 3

Individualized Obesity Pharmacotherapy

Completed
NCT04399395Phase 4

Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery

Withdrawn
NCT03581630Not Applicable

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Completed
NCT02745912Phase 1

Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7